More Than 2 Million Dogs Reach for Zen: Elanco Helps Veterinarians and Pet Owners Navigate Extended Allergy Season With Zenrelia(TM) (Ilunocitinib Tablets)
Elanco's Zenrelia (ilunocitinib tablets) has treated more than 2 million dogs across 48 countries, including the U.S., EU, UK, Brazil, Canada, Australia and Japan. Since its September 2024 U.S. launch, Zenrelia has shown 99% prescribing loyalty among surveyed U.S. veterinarians, and Elanco is promoting it ahead of a lengthened fall allergy season that Climate Central says stretched an average of 11 days from 1970 to 2025.
Key figures
- Dogs treated
- more than 2 million
- Itchy dogs us
- nearly 79 million
- Countries available
- 48
- Prescribing loyalty
- 99%
- Allergy season lengthening avg
- 11 days (1970-2025)
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.